The early effects of rapid androgen deprivation on human prostate cancer

The early effects of rapid androgen deprivation on human prostate cancer

The androgen receptor (AR) is the dominant growth factor in prostate cancer (PCa).Therefore, understanding how ARs regulate the human transcriptome is of paramountimportance. The early effects of castration on human PCa have not previously beenstudied 27 patients medically castrated with degarelix 7...

Podrobná bibliografie
Hlavní autoři:	Shaw, G, Whitaker, H, Corcoran, M, Dunning, M, Luxton, H, Kay, J, Massie, C, Miller, J, Lamb, A, Ross-Adams, H, Russell, R, Nelson, A, Eldridge, M, Lynch, A, Ramos-Montoya, A, Mills, I, Taylor, A, Arlt, W, Shah, N, Warren, A, Neal, D
Médium:	Journal article
Jazyk:	English
Vydáno:	Elsevier 2015

Podobné jednotky

The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man.
Autor: Sharma, N, a další
Vydáno: (2013)

The androgen receptor induces a distinct transcriptional program in castration resistant prostate cancer in man
Autor: Sharma, N, a další
Vydáno: (2012)

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
Autor: Ross-Adams, H, a další
Vydáno: (2015)

Lacrimal sac adenocarcinoma managed with androgen deprivation
Autor: David H. Abramson, a další
Vydáno: (2020-09-01)

Mining human prostate cancer datasets: The "camcAPP" shiny app.
Autor: Dunning, M, a další
Vydáno: (2017)

Androgen deprivation therapy promotes an obesity-like microenvironment in periprostatic fat
Autor: Stefano Mangiola, a další
Vydáno: (2019-05-01)

Androgen deprivation therapy and hormonal status in men with COVID-19
Autor: A. A. Kamalov, a další
Vydáno: (2023-01-01)

Independence of HIF1a and androgen signaling pathways in prostate cancer
Autor: Tran, MGB, a další
Vydáno: (2020)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
Autor: Shtutman Michael, a další
Vydáno: (2010-04-01)

CACNA1D overexpression and voltage-gated calcium channels in prostate cancer during androgen deprivation
Autor: McKerr, N, a další
Vydáno: (2023)

Towards derivation of a distinct signature permitting personalised treatment in prostate cancer
Autor: Lamb, A, a další
Vydáno: (2013)

Towards derivation of a distinct signature permitting personalised treatment in prostate cancer
Autor: Lamb, A, a další
Vydáno: (2012)

Androgen deprivation-induced senescence promotes outgrowth of androgen-refractory prostate cancer cells.
Autor: Dominick G A Burton, a další
Vydáno: (2013-01-01)

Randomized, Open-Label Phase 2 Study of Apalutamide plus Androgen Deprivation Therapy versus Apalutamide Monotherapy versus Androgen Deprivation Monotherapy in Patients with Biochemically Recurrent Prostate Cancer
Autor: Rahul Aggarwal, a další
Vydáno: (2022-01-01)

Integration of copy number and transcriptomics provides risk stratification in prostate cancer: A discovery and validation cohort study
Autor: H. Ross-Adams, a další
Vydáno: (2015-09-01)

Corrigendum to “Integration of Copy Number and Transcriptomics Provides Risk Stratification in Prostate Cancer: A Discovery and Validation Cohort Study” [EBioMedicine 2 (9) (2015) 1133–1144]
Autor: H. Ross-Adams, a další
Vydáno: (2017-03-01)

Relugolix: a novel androgen deprivation therapy for management of patients with advanced prostate cancer
Autor: Fred Saad, a další
Vydáno: (2021-03-01)

Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy.
Autor: Rajan, P, a další
Vydáno: (2014)

Next-generation sequencing of advanced prostate cancer treated with androgen-deprivation therapy
Autor: Rajan, P, a další
Vydáno: (2014)

CREB5 Promotes Resistance to Androgen-Receptor Antagonists and Androgen Deprivation in Prostate Cancer
Autor: Justin H. Hwang, a další
Vydáno: (2019-11-01)

How do we define “castration” in men on androgen deprivation therapy?
Autor: Sarin Itty, a další
Vydáno: (2020-01-01)

Impact of Androgen Deprivation on Oxidative Stress and Antioxidant Status in Nigerian Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
Autor: Iya Eze Bassey, a další
Vydáno: (2020-11-01)

External radiotherapy for prostate cancer with or without androgen deprivation: Geneva, 1991 to 2004
Autor: R Miralbell, a další
Vydáno: (2009-09-01)

COMBINED RADIATION THERAPY FOR PROSTATE CANCER WITH DOSE ESCALATION BRACHYTHERAPY AND ANDROGEN DEPRIVATION
Autor: Auchynikau V. A., a další
Vydáno: (2018-09-01)

Systemic interrogation of immune-oncology-related proteins in patients with locally advanced prostate cancer undergoing androgen deprivation and intensity-modulated radiotherapy
Autor: Guldvik, IJ, a další
Vydáno: (2024)

HES6 drives a critical AR transcriptional programme to induce castration‐resistant prostate cancer through activation of an E2F1‐mediated cell cycle network
Autor: Ramos-Montoya, A, a další
Vydáno: (2014)

The castration level of testosterone and hormonal resistance of prostate cancer in androgen deprivation therapy
Autor: I. G. Rusakov, a další
Vydáno: (2020-12-01)

Androgen deprivation therapy for prostate cancer: long-term safety and patient outcomes
Autor: Ahmadi H, a další
Vydáno: (2014-07-01)

Skeletal Scintigraphy in Assesing the Response of Prostate Cancer Metastases to Androgen Deprivation Therapy
Autor: S. P. Mironov, a další
Vydáno: (2021-09-01)

Effect of androgen deprivation therapy on the expression of prostate cancer biomarkers MSMB and MSMB-binding protein CRISP3.
Autor: Dahlman, A, a další
Vydáno: (2010)

Metabolomic effects of androgen deprivation therapy treatment for prostate cancer
Autor: Jen‐Tsan Chi, a další
Vydáno: (2020-06-01)

Patients’ Preferences for Androgen Deprivation Therapy in the Treatment of Intermediate-Risk Prostate Cancer
Autor: Brian De, a další
Vydáno: (2022-11-01)

POSSIBILITIES OF A COMBINATION OF DOCETAXEL WITH ANDROGEN DEPRIVATION IN INITIAL THERAPY OF HORMONESENSITIVE PROSTATE CANCER
Autor: A. A. GRITSKEVICH, a další
Vydáno: (2017-06-01)

Synthetic lethality between androgen receptor signalling and the PARP pathway in prostate cancer.
Autor: Asim, M, a další
Vydáno: (2017)

The management of sexual dysfunction resulting from radiotherapy and androgen deprivation therapy: A survey of current UK practice
Autor: W. Kinnaird, a další
Vydáno: (2020-07-01)

Prostate-specific antigen dynamics predict individual responses to intermittent androgen deprivation
Autor: Renee Brady-Nicholls, a další
Vydáno: (2020-04-01)

Independence of HIF1a and androgen signaling pathways in prostate cancer
Autor: Maxine G. B. Tran, a další
Vydáno: (2020-05-01)

Evaluation of biochemical recurrence in patients with high-risk prostate cancer treated with radical prostatectomy and radiotherapy plus androgen deprivation therapy
Autor: Yamamoto Y, a další
Vydáno: (2016-12-01)

Predictors of Fracture Risk and Bone Mineral Density in Men with Prostate Cancer on Androgen Deprivation Therapy
Autor: Katherine Neubecker, a další
Vydáno: (2011-01-01)

Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer
Autor: Røe Kathrine, a další
Vydáno: (2012-05-01)